Prognostic factors for survival in advanced thymomas: The role of the number of involved structures
- 12 July 2021
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 124 (5) , 858-866
Abstract
Background and Objectives: The Masoka‐Koga and tumor node metastases staging systems for thymoma are based on structures involved, but the prognostic role of the number of infiltrated/involved structures is still debated. We analyzed the prognostic role of involved structures and their combinations in locally advanced thymomas patients.Methods: Data on 174 surgically treated locally advanced thymoma patients from 1/01/1990 to 31/12/2015 were reviewed. Clinical and pathological characteristic, involved structures, number of involved structures and different combinations were correlated to cancer specific survival (CSS) using Kaplan–Meier product‐limit method.Results: Five and 10‐year CSS was 92% and 87%. Masaoka Stage 3 (p < 0.001), absence of pericardial involvement (p = 0.001), number of involved structures (p = 0.018), R0 (p < 0.001) and adjuvant radiotherapy (p = 0.008) were favorable prognostic CSS factors. A significant better prognosis was present in ≤2 involved structures vs >2 involved structures (5‐ and 10‐year CSS: 95% and 93% vs. 80% and 51%). Multivariable analysis confirmed as independent prognostic factor R0 (p = 0.033, hazard ratio [HR]: 0.093, 95% confidence interval [CI] 0.010–0.827) and number of involved structures (p = 0.046, HR: 0.187, 95% CI: 0.036–0.968). In Masaoka Stage 3, patients with ≤2 involved structures had a significant better CSS than patients with >2 (10‐year CSS: 98% vs. 73%, p = 0.008).Conclusions: The number of involved structures and the concomitant involvement of the pericardium seems to be associated with a poor prognosis in surgically treated advanced thymoma patients.Keywords
This publication has 19 references indexed in Scilit:
- Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experienceLung Cancer, 2019
- A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer RegistryClinical Lung Cancer, 2019
- Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant TumorsJournal of Thoracic Oncology, 2014
- The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant TumorsJournal of Thoracic Oncology, 2014
- ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and ReportingJournal of Thoracic Oncology, 2014
- Management of Stage I and II ThymomaThoracic Surgery Clinics, 2011
- Thirty-Five–Year Follow-Up Analysis of Clinical and Pathologic Outcomes of Thymoma SurgeryThe Annals of Thoracic Surgery, 2010
- Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapyEuropean Journal of Cancer, 2008
- A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non‐invasive thymomaPathology International, 1994